SLC5A2 and hydrops fetalis: In single study results, there was no evidence of an effect on the composite outcome of CVD death/HF hospitalisation in Hispanic/Latinos and non-Hispanic/Latinos comparing SGLT2-Is vs. placebo: HRs (95% CIs) of 0.76 (0.50–1.15) and 0.90 (0.76–1.07), respectively (Supplementary Appendix 8).